Additionally, we determined that ODC inhibition via the L-difluoromethylornithine (DFMO) inhibitor could reduce Aβ-mediated apoptosis as well as Aβ aggregation, thus potentially slowing AD pathology in a neuronal cell system. Here, ODC1 is linked to Alzheimer disease.